Pusztai L, Hoag JR, Albain KS, Barlow WE, et al. Development and Validation of the RSClinN+ Tool to Predict Prognosis and Chemotherapy Benefit for Hormone Receptor-Positive, Node-Positive Breast Cancer. J Clin Oncol 2024 Dec 2:JCO2401507. doi: 10.1200/JCO-24-01507.
PMID: 39621968